Beata Nowicka-Sans

<i>In Vitro</i>Antiviral Characteristics of HIV-1 Attachment Inhibitor BMS-626529, the Active Component of the Prodrug BMS-663068

Beata Nowicka-Sans, Yi-Fei Gong, Brian McAuliffe et al. · Antimicrobial Agents and Chemotherapy · 2012 · 137 citations · Full text

Prodrug Bms-663068, Hiv-1 Gp120, Medicine +13

Inhibitors of HIV-1 Attachment: The Discovery and Development of Temsavir and its Prodrug Fostemsavir

Nicholas A. Meanwell, Mark Krystal, Beata Nowicka-Sans et al. · Journal of Medicinal Chemistry · 2017 · 136 citations · Full text

Immunology, Pharmacotherapy, Antiviral Drug +16

Envelope Conformational Changes Induced by Human Immunodeficiency Virus Type 1 Attachment Inhibitors Prevent CD4 Binding and Downstream Entry Events

Hsu‐Tso Ho, Fan Li, Beata Nowicka-Sans et al. · Journal of Virology · 2006 · 108 citations · Full text

Inhibitors of Human Immunodeficiency Virus Type 1 (HIV-1) Attachment. 5. An Evolution from Indole to Azaindoles Leading to the Discovery of 1-(4-Benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridin-3-yl)ethane-1,2-dione (BMS-488043), a Drug Candidate That Demonstrates Antiviral Activity in HIV-1-Infected Subjects

Tao Wang, Zhiwei Yin, Zhongxing Zhang et al. · Journal of Medicinal Chemistry · 2009 · 98 citations · Full text

Organic Chemistry, Hiv-1-infected Subjects, Pharmacotherapy +19

Genotypic correlates of susceptibility to HIV-1 attachment inhibitor BMS-626529, the active agent of the prodrug BMS-663068

Nannan Zhou, Beata Nowicka-Sans, Brian McAuliffe et al. · Journal of Antimicrobial Chemotherapy · 2013 · 75 citations